Comprehensive Vasodilation vs Usual Care—Mortality and Rehospitalization for Heart Failure

This randomized clinical trial compares the effect of early intensive and sustained vasodilation (using nitrates, hydralazine, renin-angiotensin inhibitors, and sacubitril-valsartan) vs usual care on a composite outcome of all-cause mortality and acute heart failure rehospitalization at 180 days…

Read the full article here

Related Articles

Lipoprotein(a)

This JAMA Insights discusses lipoprotein(a), including factors associated with elevated lipoprotein(a) levels, how to manage them, and atherosclerotic cardiovascular disease risk.